
Featured
Gut Microbiome Metabolites Identified as Primary Drivers of Neuroinflammation in Early-Stage Alzheimer's Disease
Mayo Clinic researchers identify gut microbiome-derived metabolites, specifically LPS and depleted SCFAs, as primary drivers of neuroinflammation and ...
Read Full Story →

